Soluble CD14 subtype (sCD14-ST) as biomarker in neonatal early-onset sepsis and late-onset sepsis: a systematic review and meta-analysis

Early diagnosis of bacterial sepsis in neonates is hampered by non-specific symptoms and the lack of rapid responding laboratory measures. The biomarker soluble CD14 subtype (sCD14-ST) seems promising in the d...

Source: BMC Immunology - June 3, 2019 Category: Allergy & Immunology Authors: Iris van Maldeghem, Charlotte M. Nusman and Douwe H. Visser Tags: Research article Source Type: research